美国使用常温区域灌注进行循环死亡后捐献心脏移植的早期经验
本先导研究评估采用体外循环进行常温区域再灌注的循环死亡后捐献心脏移植方案的可行性。2020年1月至2021年1月共完成8例循环死亡后捐献心脏移植,所有供心均成功复苏并脱离体外循环,中位随访304天生存率100%。作者认为该方案可推广使用并将增加美国供心来源。
要点
- 8例循环死亡后捐献心脏移植中,6例单纯心脏、1例心肺、1例心肾联合移植。
- 所有供心均成功复苏并脱离体外循环,无需正性肌力药物支持。
- 中位随访304天(四分位距105-371天),生存率100%。
核心结论
- 循环死亡后捐献心脏移植结局优秀,作者认为该方案可推广使用并将增加美国供心来源。
研究设计与样本
- 先导研究,评估采用体外循环进行常温区域再灌注的循环死亡后捐献心脏移植方案的可行性。
- 2020年1月至2021年1月共完成8例循环死亡后捐献心脏移植:6例单纯心脏、1例心肺、1例心肾联合移植。
主要发现
- 所有供心均成功复苏并脱离体外循环,无需正性肌力药物支持。
- 平均乳酸水平从9.39 ± 1.47 mmol/L降至7.20 ± 0.13 mmol/L,平均钾水平从7.49 ± 1.32 mmol/L降至4.36 ± 0.67 mmol/L。
- 心肺移植受者术后因原发性肺移植物功能障碍需要静脉-动脉体外膜氧合,术后第3天撤除并顺利恢复。
- 其他所有受者仅需少量正性肌力药物支持,无需机械循环支持。
- 中位随访304天(四分位距105-371天),生存率100%。
临床怎么用
- 原文结论认为该循环死亡后捐献方案可推广使用并将增加美国供心来源,原文未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This pilot study sought to evaluate the feasibility of our donation after circulatory death (DCD) heart transplantation protocol using cardiopulmonary bypass (CPB) for normothermic regional reperfusion (NRP). METHODS: Suitable local DCD candidates were transferred to our institution. Life support was withdrawn in the operating room (OR). On declaration of circulatory death, sternotomy was performed, and the aortic arch vessels were ligated. CPB was initiated with left ventricular venting. The heart was reperfused, with correction of any metabolic abnormalities. CPB was weaned, and cardiac function was assessed at 30-minute intervals. If accepted, the heart was procured with cold preservation and transplanted into recipients in a nearby OR. RESULTS: Between January 2020 and January 2021, a total of 8 DCD heart transplants were performed: 6 isolated hearts, 1 heart-lung, and 1 combined heart and kidney. All donor hearts were successfully resuscitated and weaned from CPB without inotropic support. Average lactate and potassium levels decreased from 9.39 ± 1.47 mmol/L to 7.20 ± 0.13 mmol/L and 7.49 ± 1.32 mmol/L to 4.36 ± 0.67 mmol/L, respectively. Post-transplantation, the heart-lung transplant recipient required venoarterial extracorporeal membrane oxygenation for primary lung graft dysfunction but was decannulated on postoperative day 3 and recovered uneventfully. All other recipients required minimal inotropic support without mechanical circulatory support. Survival was 100% with a median follow-up of 304 days (interquartile range, 105-371 days). CONCLUSIONS: DCD heart transplantation outcomes have been excellent. Our DCD protocol is adoptable for more widespread use and will increase donor heart availability in the United States.
引用
- Smith DE, Kon ZN, Carillo JA, et al. Early experience with donation after circulatory death heart transplantation using normothermic regional perfusion in the United States. J Thorac Cardiovasc Surg. 2021. PMID: 34728084. doi:10.1016/j.jtcvs.2021.07.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。